Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 2011
Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complexHaoming Zhang, Chitra Sridar, Cesar Kenaan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6Chitra Sridar, Ute M Kent, Lisa M Notley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 26, 2008
Differential inhibition of cytochromes P450 3A4 and 3A5 by the newly synthesized coumarin derivatives 7-coumarin propargyl ether and 7-(4-trifluoromethyl)coumarin propargyl etherChitra Sridar, Ute M Kent, Kate Noon, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2008
The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6Natasha T Snider, Matthew J Sikora, Chitra Sridar, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 3, 2006
Synthesis of substituted phenyl diaziridines and characterization as mechanism-based inactivators of human cytochrome P450 2B6Chitra Sridar, Yoshimasa Kobayashi, Holly Brevig, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 26, 2006
Structure-activity relationship and elucidation of the determinant factor(s) responsible for the mechanism-based inactivation of cytochrome P450 2B6 by substituted phenyl diaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M Kent, et al.
Pageof 2